Zacks Investment Research
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Elevance Health (ELV) has gained 8.9% year-to-date, outperforming the Medical group's 0.2% average gain, with a Zacks Rank #2 (Buy) rating and improving analyst sentiment. American Well Corporation (AMWL) has significantly outperformed with a 161.1% year-to-date return and also holds a Zacks Rank #2 (Buy) rating with increased consensus EPS estimates.
